What is Procrit, and what is it used for?
Procrit is the brand name for epoetin alfa, a man-made version of erythropoietin (EPO), a hormone your body makes to stimulate red blood cell production. Procrit is used to treat certain types of anemia, including anemia related to chronic kidney disease and anemia caused by some cancer treatments, to help reduce the need for blood transfusions [1].
How does Procrit work?
Procrit works by binding to the same receptors that natural EPO uses in the bone marrow. This signals the body to make more red blood cells, which raises hemoglobin and hematocrit levels [1].
How is Procrit given, and who should be careful?
Procrit is typically given by injection (the specific schedule depends on the condition being treated). It is generally used under clinician supervision because correcting anemia too aggressively can increase risks such as high blood pressure and blood clots. Patients’ hemoglobin levels are monitored during treatment [1].
Is Procrit the same as other “epo” medicines?
Procrit (epoetin alfa) is one of several erythropoiesis-stimulating agents (ESAs). Other ESAs include darbepoetin alfa (Aranesp) and biosimilar versions of epoetin alfa, which may differ in dosing schedules or brand naming but share the same general mechanism (stimulating red blood cell production) [1].
Patent and manufacturer info (if you’re researching the product)
DrugPatentWatch.com tracks patent and exclusivity information for medicines, including Procrit/epoetin alfa products, which can help if you’re looking into availability, competition, or market history [1].
Sources
- https://www.drugs.com/procrit.html
- https://www.drugpatentwatch.com/p/procrit